Identification of an effective fraction from Ampelopsis Radix with anti-dengue virus activities in vitro and in vivo
Journal of Ethnopharmacology, ISSN: 0378-8741, Vol: 309, Page: 116339
2023
- 4Citations
- 10Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations4
- Citation Indexes4
- CrossRef4
- Captures10
- Readers10
- 10
- Mentions1
- News Mentions1
- 1
Most Recent News
Findings from Southern Medical University Reveals New Findings on Dengue Hemorrhagic Fever (Identification of an Effective Fraction From Ampelopsis Radix With Anti-dengue Virus Activities In Vitro and In Vivo)
2023 JUN 14 (NewsRx) -- By a News Reporter-Staff News Editor at Daily China News -- Fresh data on Mosquito-Borne Diseases - Dengue Hemorrhagic Fever
Article Description
Dengue virus (DENV) infection is a global public health issue without effective therapeutic interventions. Chinese medicine with heat-clearing and detoxifying properties has been frequently used in the treatment of viral infection. Ampelopsis Radix (AR) is a traditional Chinese medicine for clearing heat and detoxification that has been widely used in the prevention and treatment of infectious diseases. However, no studies on the effects of AR against viral infection have been reported, thus far. To explore the anti-DENV activities of the fraction (AR-1) obtained from AR both in vitro and in vivo. The chemical composition of AR-1 was identified by liquid chromatography-tandem MS (LC‒MS/MS). The antiviral activities of AR-1 were studied in baby hamster kidney fibroblast BHK-21 cells, ICR suckling mice and induction of interferon α/β (IFN-α/β) and IFN-γ R −/− (AG129) mice. Based on LC‒MS/MS analysis, 60 compounds (including flavonoids, phenols, anthraquinones, alkaloids and other types) were tentatively characterized from AR-1. AR-1 inhibited the cytopathic effect, the production of progeny virus and the synthesis of viral RNA and proteins by blocking DENV-2 binding to BHK-21 cells. Moreover, AR-1 significantly attenuated weight loss, decreased clinical scores and prolonged the survival of DENV-infected ICR suckling mice. Critically, the viral load in blood, brain and kidney tissues and the pathological changes in brain were remarkably alleviated after AR-1 treatment. Further study on AG129 mice showed that AR-1 obviously improved the clinical manifestations and survival rate, reduced viremia, attenuated gastric distension and relieved the pathological lesions caused by DENV. In summary, this is the first report that AR-1 exhibits anti-DENV effects both in vitro and in vivo, which suggests that AR-1 may be developed as a therapeutic candidate against DENV infection.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0378874123002076; http://dx.doi.org/10.1016/j.jep.2023.116339; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85150035845&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36870463; https://linkinghub.elsevier.com/retrieve/pii/S0378874123002076; https://dx.doi.org/10.1016/j.jep.2023.116339
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know